Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment

Authors
Category Primary study
JournalNoropsikiyatri Arsivi
Year 2023
This article has no abstract
Epistemonikos ID: 3112bfb3efc920f24bc811f2f94a0fa3443e9b88
First added on: Feb 15, 2025